These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 32842335)
1. [Triamcinolone acetonide deep fornix injection for the treatment of upper eyelid retraction in patients with thyroid-associated ophthalmopathy]. Luo LH; Gao LX; Wang W; Miao H; Ma XM; Li DM Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):524-529. PubMed ID: 32842335 [No Abstract] [Full Text] [Related]
2. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections. Lee SJ; Rim TH; Jang SY; Kim CY; Shin DY; Lee EJ; Lee SY; Yoon JS Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):261-70. PubMed ID: 22968823 [TBL] [Abstract][Full Text] [Related]
3. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy. Xu D; Liu Y; Xu H; Li H Can J Ophthalmol; 2012 Feb; 47(1):34-41. PubMed ID: 22333849 [TBL] [Abstract][Full Text] [Related]
4. Long-term effect of triamcinolone acetonide in the treatment of upper lid retraction with thyroid associated ophthalmopathy. Xu DD; Chen Y; Xu HY; Li H; Zhang ZH; Liu YH Int J Ophthalmol; 2018; 11(8):1290-1295. PubMed ID: 30140631 [TBL] [Abstract][Full Text] [Related]
5. Triamcinolone acetonide injection in the treatment of upper eyelid retraction in Graves' ophthalmopathy evaluated by 3.0 Tesla magnetic resonance imaging. Duan M; Xu DD; Zhou HL; Fang HY; Meng W; Wang YN; Jin ZY; Chen Y; Zhang ZH Indian J Ophthalmol; 2022 May; 70(5):1736-1741. PubMed ID: 35502063 [TBL] [Abstract][Full Text] [Related]
6. Transconjunctival Triamcinolone Injection for Upper Lid Retraction in Thyroid Eye Disease-A New Injection Method. Young SM; Kim YD; Lang SS; Woo KI Ophthalmic Plast Reconstr Surg; 2018; 34(6):587-593. PubMed ID: 29672347 [TBL] [Abstract][Full Text] [Related]
7. Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease. Lee JM; Lee H; Park M; Baek S J Craniofac Surg; 2012 Nov; 23(6):1755-8. PubMed ID: 23147303 [TBL] [Abstract][Full Text] [Related]
8. [Acellular xenogenic dermal matrix as a spacer graft for treatment of eyelid retraction related to thyroid associated ophthalmopathy]. Zhuang A; Sun J; Zhang S; Zhou HF Zhonghua Yan Ke Za Zhi; 2019 Nov; 55(11):821-827. PubMed ID: 31715678 [No Abstract] [Full Text] [Related]
9. Subcutaneous Injections of Triamcinolone Acetonide for Upper Eyelid Retraction and Swelling Associated with Thyroid Eye Disease: A Retrospective Case Series Study. Kozaki A; Inoue R; Yaji N; Nishiyama K; Inoue T Clin Ophthalmol; 2024; 18():2147-2154. PubMed ID: 39070106 [TBL] [Abstract][Full Text] [Related]
10. Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy. Li D; Sun F Biomed Res Int; 2021; 2021():9514279. PubMed ID: 33791385 [TBL] [Abstract][Full Text] [Related]
11. Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: a case series. Chee E; Chee SP Eye (Lond); 2008 Feb; 22(2):311-5. PubMed ID: 17917686 [TBL] [Abstract][Full Text] [Related]
13. Change in upper eyelid position after teprotumumab treatment for thyroid eye disease. Rosenblatt TR; Chiou CA; Yoon MK; Lee NG; Wolkow N; Freitag SK Orbit; 2024 Jun; 43(3):337-343. PubMed ID: 38466206 [TBL] [Abstract][Full Text] [Related]
14. Shallow periorbital injection of triamcinolone acetonide in treatment of lower eyelid entropion related to thyroid-associated ophthalmopathy: Three case reports. Mo F; Xu D; Xu H; Li G; Gao Y; Li H Medicine (Baltimore); 2020 Jan; 99(5):e19026. PubMed ID: 32000449 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid gel injection for upper eyelid retraction in thyroid eye disease: functional and dynamic high-resolution ultrasound evaluation. Kohn JC; Rootman DB; Liu W; Goh AS; Hwang CJ; Goldberg RA Ophthalmic Plast Reconstr Surg; 2014; 30(5):400-4. PubMed ID: 24833450 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous triamcinolone injection for upper eyelid retraction in thyroid eye disease. Parsons SR; Wilson-Pogmore A; Sullivan TJ Front Ophthalmol (Lausanne); 2024; 4():1388197. PubMed ID: 38984143 [TBL] [Abstract][Full Text] [Related]
17. [The influence factors of quality-of-life in patients with thyroid-associated ophthalmopathy]. Shen L; Zhu H; Li XX; Liu DD; Chen XY; Liu H Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):575-582. PubMed ID: 28851197 [No Abstract] [Full Text] [Related]
18. Modified Full Thickness Graded Blepharotomy for Upper Eyelid Retraction Associated With Thyroid Eye Disease in East Asians. Lee J; Lee H; Park M; Baek S Ann Plast Surg; 2016 Dec; 77(6):592-596. PubMed ID: 26545229 [TBL] [Abstract][Full Text] [Related]
19. Peri-levator Betamethasone Versus Triamcinolone Injection in Management of Thyroid Eye Disease-related Upper Eyelid Retraction Without Proptosis. Awad RA; Abo-Ghadir AA; Hussien MS; Awad AA; Kedwany SM; Mohammad AEA Ophthalmic Plast Reconstr Surg; 2024 Nov-Dec 01; 40(6):610-616. PubMed ID: 39012874 [TBL] [Abstract][Full Text] [Related]
20. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy. Choi SW; Lee JY; Lew H Korean J Ophthalmol; 2016 Feb; 30(1):1-9. PubMed ID: 26865797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]